SS
ORGO icon

SBI Securities’s Organogenesis Holdings ORGO Stock Holding History

SBI Securities’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156 Sell
64
-1
-2% -$2 ﹤0.01% 3393
2026
Q1 		$154 Buy
65
+33
+103% +$114 ﹤0.01% 3304
2025
Q4 		$166 Buy
32
+15
+88% +$73 ﹤0.01% 3269
2025
Q3 		$72 Sell
17
-247
-94% -$1.15K ﹤0.01% 3609
2025
Q2 		$966 Buy
264
+252
+2,100% +$939 ﹤0.01% 2697
2025
Q1 		$52 Buy
12
+6
+100% +$24 ﹤0.01% 3633
2024
Q4 		$19 Buy
+6
New +$20 ﹤0.01% 3847

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SBI Securities's ORGO Position: Q2 2026 in Review

SBI Securities reduced its Organogenesis Holdings (ORGO) stake by 1.5% in Q2 2026, selling an estimated $2 and leaving 64 shares worth $156. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

SBI Securities first reported a position in ORGO in Q4 2024 and has held it in 7 quarters since. The position peaked at $966 in Q2 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • SBI Securities held 64 shares of Organogenesis Holdings worth $156 as of Q2 2026.
  • SBI Securities sold 1 Organogenesis Holdings share in Q2 2026, an estimated $2.
  • Organogenesis Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3393 holding.
  • SBI Securities first reported a position in Organogenesis Holdings in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Organogenesis Holdings position peaked at $966 in Q2 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.